These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

742 related items for PubMed ID: 15837993

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
    Beck SD, Cheng L, Bihrle R, Donohue JP, Foster RS.
    J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
    Beck SD, Foster RS, Bihrle R, Donohue JP, Einhorn LH.
    Cancer; 2007 Sep 15; 110(6):1235-40. PubMed ID: 17665498
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
    Brown JA, Bihrle R, Foster RS.
    Urology; 2008 May 15; 71(5):911-4. PubMed ID: 18342916
    [Abstract] [Full Text] [Related]

  • 31. Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.
    Kondagunta GV, Motzer RJ.
    Urol Clin North Am; 2007 May 15; 34(2):179-85; abstract ix. PubMed ID: 17484923
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.
    Ehrlich Y, Yossepowitch O, Kedar D, Baniel J.
    BJU Int; 2006 Jun 15; 97(6):1221-4. PubMed ID: 16686715
    [Abstract] [Full Text] [Related]

  • 34. Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: a comparison study.
    Poulakis V, Skriapas K, de Vries R, Dillenburg W, Ferakis N, Witzsch U, Becht E.
    Urology; 2006 Jul 15; 68(1):154-60. PubMed ID: 16820195
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
    Peterson M, Beck S, Bihrle R, Einhorn L, Foster R.
    BJU Int; 2009 Jul 15; 104(2):176-8. PubMed ID: 19493258
    [Abstract] [Full Text] [Related]

  • 37. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE, Tannir NM, Brown GA, Liu P, Tu SM, Evans JG, Pisters LL.
    Urology; 2007 Dec 15; 70(6):1173-8. PubMed ID: 18158041
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Management of low-stage nonseminomatous germ cell tumors of testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
    Stephenson AJ, Aprikian AG, Gilligan TD, Oldenburg J, Powles T, Toner GC, Waters WB.
    Urology; 2011 Oct 15; 78(4 Suppl):S444-55. PubMed ID: 21986224
    [Abstract] [Full Text] [Related]

  • 40. Surgery for testicular cancer: indication, results and technical aspects.
    Khouni H, Ghozzi S, Ramzi K, Smaali CH, Majed H, Ben Rais N.
    Tunis Med; 2005 Dec 15; 83 Suppl 12():78-83. PubMed ID: 16430075
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.